Glucosphingolipids as sites of action in the chemotherapy of cancer.
Radin
N S
NS
Mental Health Research Institute, University of Michigan, Ann Arbor 48109.
Inokuchi
J
J
D000818:Animals; D000906:Antibodies / Q000008:administration & dosage; D005963:Glucosylceramides / Q000494:pharmacology; D006028:Glycosphingolipids / Q000097:blood / Q000276:immunology / Q000378:metabolism*; D006801:Humans; D007167:Immunotherapy; D051379:Mice; D009369:Neoplasms / Q000209:etiology / Q000378:metabolism* / Q000628:therapy
D000906:Antibodies; D005963:Glucosylceramides; D006028:Glycosphingolipids